Shaping the future of European epilepsy research: Final meeting report from EPICLUSTER
暂无分享,去创建一个
S. Sisodiya | A. Pitkänen | S. Dedeurwaerdere | H. Lerche | M. Kokaia | R. Guerrini | D. Henshall | S. Jóźwiak | A. Arzimanoglou | M. Simonato | Philippe Ryvlin
[1] Anthony Maher,et al. Applying Patient and Public Involvement in preclinical research: A co‐created scoping review , 2022, Health expectations : an international journal of public participation in health care and health policy.
[2] F. Ginhoux,et al. Single-cell transcriptomics and surface epitope detection in human brain epileptic lesions identifies pro-inflammatory signaling , 2022, Nature neuroscience.
[3] S. Schorge,et al. Gene Therapy for Neurological Disease: State of the Art and Opportunities for Next-generation Approaches , 2022, Neuroscience.
[4] M. Brodie,et al. Meeting report: EpiXchange II brings together European epilepsy research projects to discuss latest advances , 2021, Epilepsy Research.
[5] M. Lalu,et al. Patient engagement in preclinical laboratory research: A scoping review , 2021, EBioMedicine.
[6] N. Delanty,et al. Democratizing epilepsy care: Utility and usability of an electronic patient portal , 2021, Epilepsy & Behavior.
[7] A. Pitkänen,et al. Identification of clinically relevant biomarkers of epileptogenesis — a strategic roadmap , 2021, Nature Reviews Neurology.
[8] Derek Corrigan,et al. LoVE in a time of CoVID: Clinician and patient experience using telemedicine for chronic epilepsy management , 2020, Epilepsy & Behavior.
[9] Madeline A. Lancaster,et al. Brain organoids for the study of human neurobiology at the interface of in vitro and in vivo , 2020, Nature Neuroscience.
[10] Brian Litt,et al. Multimodal in vivo recording using transparent graphene microelectrodes illuminates spatiotemporal seizure dynamics at the microscale , 2020, bioRxiv.
[11] Josemir W Sander,et al. Psychiatric Comorbidities in People With Epilepsy. , 2020, Neurology. Clinical practice.
[12] L. Concha,et al. Network-based atrophy modeling in the common epilepsies: A worldwide ENIGMA study , 2020, Science Advances.
[13] P. Kwan,et al. 30 years of second-generation antiseizure medications: impact and future perspectives , 2020, The Lancet Neurology.
[14] H. Mefford,et al. Epilepsy Benchmarks Area III: Improved Treatment Options for Controlling Seizures and Epilepsy-Related Conditions Without Side Effects , 2020, Epilepsy currents.
[15] D. Binder,et al. Epilepsy Benchmarks Area II: Prevent Epilepsy and Its Progression , 2020, Epilepsy currents.
[16] E. Marsh,et al. Epilepsy Benchmarks Area I: Understanding the Causes of the Epilepsies and Epilepsy-Related Neurologic, Psychiatric, and Somatic Conditions , 2020, Epilepsy currents.
[17] E. Felton,et al. Epilepsy Benchmarks Area IV: Limit or Prevent Adverse Consequence of Seizures and Their Treatment Across the Life Span , 2020, Epilepsy currents.
[18] D. Kullmann,et al. Novel therapies for epilepsy in the pipeline , 2019, Epilepsy & Behavior.
[19] S. Sisodiya,et al. Advancing research toward faster diagnosis, better treatment, and end of stigma in epilepsy , 2019, Epilepsia.
[20] Anthony G. Wilson,et al. Facilitating public and patient involvement in basic and preclinical health research , 2019, PloS one.
[21] Fares Alahdab,et al. Global, regional, and national burden of epilepsy, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 , 2019, The Lancet Neurology.
[22] L. Forsythe,et al. Evaluating patient and public involvement in research , 2018, British Medical Journal.
[23] James G. Scott,et al. Global Epidemiology and Burden of Schizophrenia: Findings From the Global Burden of Disease Study 2016 , 2018, Schizophrenia bulletin.
[24] D. Kullmann,et al. In vivo CRISPRa decreases seizures and rescues cognitive deficits in a rodent model of epilepsy , 2020, Brain : a journal of neurology.
[25] Eyal Oren,et al. Global, regional, and national burden of neurological disorders, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 , 2017, The Lancet. Neurology.
[26] Philippe Ryvlin,et al. Biallelic variants in LARS2 and KARS cause deafness and (ovario)leukodystrophy , 2017, Neurology.
[27] B. Jespersen,et al. Optogenetic control of human neurons in organotypic brain cultures , 2016, Scientific Reports.
[28] Orrin Devinsky,et al. Sudden, unexpected death in epilepsy. , 2011, The New England journal of medicine.